NCT02789644

Clinical Trial to Investigate Pharmacokinetics, Metabolomics and Biomarker in Elderly After UDCA Administration

A Randomized, Open-label Clinical Trial to Investigate Pharmacokinetics, Metabolomics and Biomarker in Healthy Elderly Subjects After Ursodeoxycholic Acid Administration

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (estimated)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 70 Years – 84 Years
• Healthy volunteers: Accepted

Summary

A clinical study to investigate pharmacokinetics, metabolomics and biomarker in healthy elderly subject after ursodeoxycholic acid administration

Detailed description

This study has a randomized, open-label, two-treatment, one-sequence, multiple drug administration design. The purpose of this study is as follows; To investigate pharmacokinetics, metabolomics and biomarker in healthy elderly subject after ursodeoxycholic acid administration

Conditions

• Aged

Interventions

Type	Name	Description
DRUG	Ursodeoxycholic Acid	Day 1: Ursodeoxycholic acid 400mg or 800mg qd Day 2 to 15: Ursodeoxycholic acid 200mg bid

Timeline

• Start date: 2016-05-01
• Primary completion: 2016-07-01
• Completion: 2016-07-01
• First posted: 2016-06-03
• Last updated: 2016-06-03

Locations

1 site across 1 country: South Korea